Stock-picking hedge funds have delivered a standout performance in the first half of the year, with a key group tracked by Goldman Sachs posting gains of about 17% year-to-date. The strong showing, driven largely by healthcare investments and bigger position sizes, marks a notable rebound for active managers who have often struggled to keep pace with passive index funds.
What Are Fundamental Long-Short Funds?
Fundamental long-short funds are a type of hedge fund that combines two strategies. Managers buy stocks they expect to rise (long positions) while simultaneously selling borrowed shares of stocks they expect to fall (short positions). The goal is to profit from both winners and losers, while reducing overall market risk. Unlike pure index investing, these funds rely on in-depth research and stock selection—hence the term "fundamental."
Goldman Sachs' analysis tracks a specific group of these funds, and the 17% gain through June represents a sharp outperformance compared to broader market benchmarks. For context, the S&P 500 returned roughly 15% in the same period, meaning these active managers not only kept up but beat the market by a meaningful margin.
Healthcare Bets and Bigger Positions Drive Returns
According to Goldman Sachs, healthcare stocks were a major contributor to the gains. The sector has seen significant volatility and innovation, from drug approvals to regulatory changes, creating opportunities for stock pickers who can identify winners and losers. Larger position sizes—meaning funds concentrated their bets in fewer, higher-conviction stocks—also played a key role in boosting returns.
This approach contrasts with more diversified strategies that spread risk across many holdings. By focusing on their best ideas, these managers amplified gains when those picks performed well. However, it also means they are more exposed to losses if those same bets go wrong.
What It Means for Everyday Investors
For ordinary investors, the strong hedge fund performance is a reminder that active management can still deliver results, especially in certain market conditions. But it comes with caveats. Hedge funds typically charge high fees—often a 2% management fee and 20% of profits—which can eat into returns. The 17% gain reported by Goldman Sachs is likely before fees, so net returns to investors would be lower.
Additionally, hedge funds are generally only available to accredited investors with high net worth, not the average retail investor. However, the underlying lesson—that concentrated bets on specific sectors like healthcare can pay off—may be relevant for those building their own portfolios. Diversification remains important, but understanding where professional money is flowing can offer clues about market trends.
Goldman Sachs itself has been in the news for other reasons recently. An analyst at Oppenheimer recently downgraded Goldman Sachs and Morgan Stanley, citing stretched valuations. Meanwhile, the bank's private credit fund has seen low redemptions compared to peers, suggesting stability in that part of its business.
Broader Market Context
The strong first half for hedge funds comes against a backdrop of resilient equity markets, despite concerns about interest rates, inflation, and geopolitical tensions. The Federal Reserve has held rates steady, and corporate earnings have generally been solid, providing a tailwind for stock pickers.
However, the second half of the year could bring new challenges. Market volatility often increases in the fall, and uncertainties around the U.S. election, energy prices, and global growth could test the skills of even the best fund managers. Investors will be watching closely to see if these hedge funds can sustain their momentum.
In other markets news, the yuan has held steady as the dollar eased, and the People's Bank of China has introduced new tools to manage short-term funding rates, including an overnight reverse repo facility. These moves signal ongoing efforts to stabilize financial conditions globally.
The Bottom Line
Hedge fund stock pickers have had a standout first half, with fundamental long-short funds gaining about 17% year-to-date. Healthcare bets and larger position sizes were the main drivers. While these returns are impressive, everyday investors should remember that hedge fund performance is often reported before fees and may not be accessible to most. Still, the success of concentrated, research-driven strategies offers a useful case study in how active management can outperform in the right environment.
